PG
OSIR

PEAK6 Group’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

PEAK6 Group’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-14,900
Closed -$155K – 5633
2015
Q4 		$155K Buy
14,900
+12,025
+418% +$163K ﹤0.01% 3643
2015
Q3 		$53K Buy
+2,875
New +$55.5K ﹤0.01% 4629

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
QI
QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

PEAK6 Group's OSIR Position: Q1 2016 in Review

PEAK6 Group sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2016, closing a stake of 14,900 shares — an estimated $155K sold.

PEAK6 Group first reported a position in OSIR in Q3 2015 and held it in 2 quarters. The position peaked at $155K in Q4 2015. 80 funds tracked by Wall St. Rank hold OSIR as of Q1 2016.

  • PEAK6 Group reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • PEAK6 Group sold 14,900 Osiris Therapeutics, Inc. Common Stock shares in Q1 2016, an estimated $155K.
  • PEAK6 Group first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2015 and held it in 2 quarters.
  • PEAK6 Group's Osiris Therapeutics, Inc. Common Stock position peaked at $155K in Q4 2015.
  • 80 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2016.

Based on PEAK6 Group's 13F filing for Q1 2016, filed 13 May 2016.